Jump to search

March 2018arrow

Spanish questionnaire expected to reduce disparities in speech treatment for cleft-palate patients

March 15, 2018

The Spanish version of a questionnaire used to assess the speech and quality-of- life of children and young adults following cleft-palate surgery has been developed by craniofacial disorder specialists at UC Davis Health and the University of Utah.

Acute myeloid leukemia patients have reduced early mortality at NCI-designated cancer centers

March 8, 2018

Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.

UC Davis researchers find new way to defeat HIV latency

March 7, 2018

Researchers at UC Davis Health, together with colleagues at UC San Francisco and the University of North Carolina at Chapel Hill, have found a mechanism for making HIV come out of hiding and become susceptible to anti-HIV drugs. Their study is now published in The Journal of Clinical Investigation.

New molecular target could help ease asthma

March 6, 2018

Researchers at UC Davis Health and Albany Medical College have shown that the protein vascular endothelial growth factor A — or VEGFA — plays a major role in the inflammation and airway obstruction associated with asthma. The finding may eventually lead to new asthma treatments targeting VEGFA.

February 2018arrow

A small pay increase can have big health benefits for lower-wage workers

February 28, 2018

Lower-wage workers who receive a $1 raise call in sick less and consider themselves healthier than those who do not, new UC Davis research on minimum-wage policies shows.

UC Davis School of Medicine research funding ranks among the top 26 institutions in the U.S.

February 16, 2018

For the first time, UC Davis School of Medicine has ranked in the top 20 percent of institutions in the country for research funding from the National Institutes of Health (NIH).  

New study to evaluate the potential links between ozone and COPD

February 14, 2018

Angela Haczku, a leading researcher on environmental causes for airway inflammation, will receive more than $900,000 from the Tobacco Related-Disease Research Program to study chronic obstructive pulmonary disease (COPD) and ozone, a toxic component of urban smog.

Young cancer survivors' risk of heart disease related to race and socioeconomic factors

February 9, 2018

Adolescent and young adult cancer survivors who are African American, poor or have public or no health insurance are far more likely to suffer from coronary artery disease, heart failure or stroke later in life than non-Hispanic white cancer survivors.

Traveling hands-on exhibit visits UC Davis Medical Center, Feb. 6 and 9

February 6, 2018

UC Davis Health is hosting the National Institutes of Health’s All of Us Journey, a traveling, hands-on exhibit to raise awareness about precision medicine and the All of Us research program.

Northern Californians asked to complete fire impacts survey

February 5, 2018

UC Davis public health researchers are conducting a comprehensive assessment of the health effects of the Northern California fires in October. They are asking one person per household in Napa, Sonoma and other counties affected by the fires to answer an online questionnaire — called the UC Davis Northern California Fire and Health Impacts Survey — about their daily lives, property and health before the fires occurred and immediately afterward, along with their current situations.

New research suggests your own immune system can protect against MRSA infections

February 5, 2018

After years of investigation, researchers at UC Davis, Johns Hopkins, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph). The findings, publishing online this week in The Journal of Clinical Investigation, open new doors to someday developing vaccines to prevent staph skin infections, which account for 14 million outpatient visits, nearly 500,000 hospital admissions and $3 billion to $4 billion in inpatient health care costs in the U.S. per year.

January 2018arrow

National study finds substantial unmet needs for mental health care among veterans of recent wars

January 31, 2018

A new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine released today has concluded that there is a substantial unmet need for mental health services among veterans of the recent wars in Afghanistan and Iraq. 

Talamantes honored as an Emerging Scholar

January 25, 2018

Efrain Talamantes, an assistant professor of internal medicine and an expert in advancing equity and diversity in the field of medicine, has been named an Emerging Scholar for 2018 by the publication Diverse: Issues in Higher Education.

Researchers say medical licensing test should include more prescription drug safety, misuse questions

January 24, 2018

Research led by experts from the UC Davis schools of medicine and nursing has identified gaps in pain-related education for health care providers that leave out important aspects of safe and effective pain management competencies, including those specific to opioid safety. These findings, said the researchers, may help explain one reason for the current public health crisis of inappropriate pain management and prescription drug abuse.

Testing Sonoma ash and air for fire-formed pollutants

January 23, 2018

When fires ripped through suburban subdivisions in Santa Rosa last October, they may have done more than reduce homes to ashes. By incinerating all kinds of materials — insulation, electronics, furniture, cleaning products, pesticides — at very high temperatures, they could have created unknown or previously unrecognized health hazards in the smoke and ash. Researchers from the University of California, Davis, are trying to figure out just what is in that ash and air.

UC Davis researcher urges caution on engineered stem cells

January 3, 2018

In a commentary published today in the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse animal models.